Functional Magnetic Stimulation (FMS) for Bone Marrow Edema in Athletes
The Effectiveness of Functional Magnetic Stimulation in the Physiotherapeutic Rehabilitation of Athletes With Bone Marrow Edema: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
This randomized controlled trial evaluates whether Functional Magnetic Stimulation (FMS) can provide additional benefits when combined with a structured physiotherapy rehabilitation program in athletes with MRI-confirmed tibial bone stress injury and associated bone marrow edema. A total of 40 athletes with Fredericson grade 2 or 3 lesions are allocated to either a combined intervention group receiving FMS plus rehabilitation or a control group receiving rehabilitation alone. The intervention period lasts four weeks. Participants in both groups follow the same load-based rehabilitation program, while those in the FMS group also receive eight 30-minute FMS sessions. Assessments are performed at baseline, after the four-week intervention, and at 16 weeks. The evaluated outcomes include activity-related tibial pain, lower-limb functional ability, MRI-measured bone marrow edema extent, and Fredericson MRI grade. The purpose of the study is to examine whether adding FMS to standardized rehabilitation leads to greater clinical, functional, and MRI-derived improvement compared with rehabilitation alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
November 18, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2026
CompletedJuly 1, 2026
June 1, 2026
7 months
November 14, 2025
June 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in tibial pain during a standardized walking task
Description: Pain related to loading of the affected tibia is measured with the Numeric Pain Rating Scale, an 11-point scale ranging from 0 to 10. A score of 0 indicates absence of pain, while a score of 10 indicates the highest possible pain intensity. At each assessment, participants complete a standardized treadmill walking task and report the greatest tibial pain experienced during the test. The walking speed selected at the initial assessment is kept the same for each participant at follow-up measurements, allowing pain to be evaluated under comparable loading conditions. Higher scores reflect greater symptom severity.
baseline, week 4, week 16
Secondary Outcomes (3)
Changes in lower-limb functional ability with the Greek Version of the Lower Extremity Functional Scale (LEFS-GR)
baseline, week 4, week 16
Change in MRI-derived bone marrow edema extent
baseline, week 4, week 16
Change in Fredericson MRI grade
baseline, week 4, week 16
Study Arms (2)
Functional Magnetic Stimulation plus standardized physiotherapy rehabilitation
EXPERIMENTALArm Description: Participants receive 12 physiotherapy rehabilitation sessions over four weeks plus eight 30-minute FMS sessions applied over the symptomatic tibial region.
Physiotherapy rehabilitation alone
ACTIVE COMPARATORParticipants in this group complete 12 supervised physiotherapy rehabilitation sessions over a four-week period and do not receive Functional Magnetic Stimulation.
Interventions
Participants in this arm complete a supervised four-week rehabilitation program delivered three times per week, for a total of 12 sessions of approximately 45 minutes each. The program focuses on symptom-guided activity modification, progressive lower-limb loading, strengthening, mobility exercises, neuromuscular control, home-based exercise guidance, and gradual return to impact-related activity. In addition, participants receive Functional Magnetic Stimulation twice per week for four weeks, resulting in eight sessions in total. Each FMS session lasts 30 minutes and is applied over the symptomatic tibial region. Stimulation is delivered at 40 Hz, with repeated cycles of 3 seconds of stimulation followed by 6 seconds of rest. Intensity is increased gradually according to participant tolerance, while avoiding pain, excessive discomfort, or overly strong muscle contractions.
Participants in this group will follow the same standardized physiotherapy protocol as the first group, without the application of FMS
Eligibility Criteria
You may qualify if:
- Age between 18 and 45 years.
- Regular participation in sports training at least three times per week during the previous six months.
- MRI-confirmed tibial bone stress injury classified as Fredericson grade 2 or grade 3.
- Localized tibial pain provoked by loading activity.
- Activity-related pain intensity of at least 3/10 on the Numeric Pain Rating Scale.
- Written informed consent provided before participation.
You may not qualify if:
- Fredericson grade 4 injury or visible fracture line on MRI.
- Bone marrow edema related to infection, tumor, systemic inflammatory disease, or another non-mechanical cause.
- History of fracture, surgery, or intra-articular/peri-osseous injection in the affected lower limb within the previous 12 weeks.
- Previous Functional Magnetic Stimulation or Extracorporeal Shockwave Therapy within the previous 8 weeks.
- Contraindications to magnetic stimulation, including pacemaker, implanted neurostimulator, cochlear implant, or significant metallic implant in or near the treatment area.
- Pregnancy or breastfeeding.
- Any neurological, metabolic, cardiovascular, or systemic condition that could affect safe participation or interpretation of study outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physiotherapy, Faculty of Health Sciences International Hellenic University
Thessaloniki, Sindos, 57400, Greece
Study Officials
- STUDY CHAIR
Paris Iakovidis, PhD
International Hellenic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A masked assessor will conduct the measurements
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Physiotherapy
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 18, 2025
Study Start
December 1, 2025
Primary Completion
June 29, 2026
Study Completion
June 29, 2026
Last Updated
July 1, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share